Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE Read more
Theolytics starts a £1M project in collaboration with the University of Sheffield, supported by Innovate UK to develop a novel therapy for multiple myeloma patients Read more
Cocrystal Pharma Expands Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate COVID-19 Protease Inhibitors Read more
Amneal Launches LYVISPAH (baclofen) for Spasticity Related to Multiple Sclerosis and Other Spinal Cord Disorders Read more
Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology Read more
FDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy (SMA) Read more
Bone Therapeutics signs definitive subscription agreement for a maximum of EUR 5M convertible bonds facility with ABO Read more
Takeda and Moderna Announce Plans to Transfer Marketing Authorization for SpikevaxTM COVID-19 Vaccine in Japan to Moderna Read more